SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player.

Square Pharmaceuticals Limited
Year of Establishment (Initially as a Partnership) : 1958
Incorporated as a Private Limited Company : 1964
Technical Collaboration Agreement with Janssen Pharmaceuticals of Belgium
(A subsidiary of Johnson & Johnson International Ltd.)
: 1974
Technical Collaboration Agreement with F.Hoffman-La Roche & Co. Ltd. : 1982
Converted into Public Limited Company : 1991
Initially Public Offering (IPO) of shares of SQUARE Pharmaceuticals Ltd. : 1994
Stock Exchange Listing (Dhaka & Chittagong) : 1995
Agreement with M/s. Bovis Tanvec Ltd. of UK for implementation of Dhaka Plant : 1996
Awarded ISO-9001 Certificate : 1998
SQUARE Pharmaceuticals Ltd., Dhaka Unit gets the UK MHRA approval : 2007
Awarded TGA Certificate : 2012
Awarded “AA+” rating in the long term and ”ST-1” rating in short term by CRISL : 2013
PAI (Pre Approval Inspection) by US FDA was successful for Dhaka Site’s solid dosage unit and WHO approved Square’s GMP         : 2015
Business Lines : Manufacturing and Marketing of Pharmaceutical Finished Products, Basic Chemicals, AgroVet Products and Pesticide Products
Authorized Capital : Tk. 10,000 Million
Paid-up Capital : Tk. 6,235 million
Number of Employees : 6,710
Subsidiary Company : Square Formulations Ltd.
Associate Company : Square Textiles Ltd.
Square Fashions Ltd.
Square Hospitals Ltd.
Join us on